{
  "compound": "Dronabinol (Marinol)",
  "condition": "ALZHEIMERS",
  "effect_size": "Large (46% reduction)",
  "study_type": "RCT",
  "source": "NORML:ALZHEIMERS_RCT_001",
  "participants": "15 patients with Alzheimer's disease",
  "year": 2006,
  "notes": "Dronabinol for Agitation in Alzheimer's Disease: Pilot RCT",
  "confidence": "medium",
  "abstract": "NPI agitation reduced 46% (p<0.01); Motor activity increased (circadian improvement); Weight gain in 6 patients"
}